Your browser doesn't support javascript.
loading
Selective Plasma Exchange for the Removal of Pemphigus Autoantibodies, Fibrinogen, and Factor XIII in Pemphigus Vulgaris.
Miyamoto, Satoko; Ohkubo, Atsushi; Seshima, Hiroshi; Komori, Shigeto; Yamamoto, Motoki; Maeda, Takuma; Itagaki, Ayako; Yamamoto, Hiroko; Nojima, Kohei; Iimori, Soichiro; Naito, Shotaro; Kurashima, Naoki; Sohara, Eisei; Rai, Tatemitsu; Uchida, Shinichi; Okado, Tomokazu.
Afiliação
  • Miyamoto S; Medical Engineering Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan.
  • Ohkubo A; Medical Engineering Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan.
  • Seshima H; Medical Engineering Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan.
  • Komori S; Medical Engineering Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan.
  • Yamamoto M; Medical Engineering Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan.
  • Maeda T; Medical Engineering Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan.
  • Itagaki A; Medical Engineering Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan.
  • Yamamoto H; Medical Engineering Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan.
  • Nojima K; Department of Dermatology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Iimori S; Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Naito S; Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kurashima N; Medical Engineering Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan.
  • Sohara E; Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Rai T; Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Uchida S; Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Okado T; Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan.
Ther Apher Dial ; 21(3): 226-231, 2017 Jun.
Article em En | MEDLINE | ID: mdl-28661086
ABSTRACT
Pemphigus vulgaris is a serious autoimmune skin disorder associated with desmoglein 1 and 3. Selective plasma exchange (SePE) for pemphigus vulgaris remains unknown. We investigated the removal characteristics of pemphigus autoantibodies, immunoglobulins, and fibrinogen in three cases. When the mean processed volume for SePE was 1.2 plasma volumes, the mean percent reduction was 50.7% for desmoglein 1, 48.9% for desmoglein 3, 50.3% for IgG, 29.8% for IgA, 1.9% for IgM, and 17.6% for fibrinogen. In one case, the percent reduction after four sessions of SePE within eight days was 87.0% for desmoglein 1, 85.1% for desmoglein 3, 76.6% for IgG, 53.5% for IgA, 7.9% for IgM, 41.6% for fibrinogen, and 31.4% for factor XIII. SePE can effectively remove pemphigus autoantibodies and retain coagulation factors, e.g. factor XIII and fibrinogen. In severe cases, SePE can be useful and safe for induction therapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Troca Plasmática / Autoanticorpos / Fator XIII / Fibrinogênio / Pênfigo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ther Apher Dial Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Troca Plasmática / Autoanticorpos / Fator XIII / Fibrinogênio / Pênfigo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ther Apher Dial Ano de publicação: 2017 Tipo de documento: Article